Population pharmacokinetics of cefazolin in maternal and umbilical cord plasma, and simulated exposure in term neonates.

Elkayal, Omar; Allegaert, Karel; Spriet, Isabel; Smits, Anne; Seghaye, Marie-Christine; Charlier, Corinne; Dreesen, Erwin

Elkayal, Omar; Allegaert, Karel; Spriet, Isabel; Smits, Anne; Seghaye, Marie-Christine; Charlier, Corinne; Dreesen, Erwin.

Afiliação

Elkayal O; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Allegaert K; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Spriet I; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Smits A; Department of Clinical Pharmacy, Erasmus MC Rotterdam, Rotterdam, The Netherlands.
Seghaye MC; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Charlier C; Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.
Dreesen E; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.

J Antimicrob Chemother ; 76(12): 3229-3236, 2021 11 12.

Article em En | MEDLINE | ID: mdl-34499720

Assuntos

Antibacterianos; Cefazolina; Adulto; Feminino; Humanos; Recém-Nascido; Plasma; Gravidez; Streptococcus agalactiae; Cordão Umbilical; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cefazolina / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Newborn / Pregnancy Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google